Pfizer seeks the next big idea in healthy aging with Indiegogo partner promotion


Pfizer is looking for a few “old” ideas. In a first for pharma companies, Pfizer has partnered with crowdfunder Indiegogo to gather new ideas about healthy aging as part of its “Get Old” campaign.

The contest is open to anyone with health and wellness ideas for products or services related to improving lives as people age and making a difference in body, mind or spirit. Submissions will be gathered until June 28 and then narrowed down to four. Those four will be featured on Pfizer’s corporate and Get Old web sites and voted on by the 400,000 members of that community to narrow down to two. Pfizer will then choose the winner, who will receive $50,000 and the chance to meet with Pfizer experts to help bring the idea to reality.

“Crowdfunding has made it possible to bring entrepreneurs the resources they need to provide life-changing innovations to people around the world. We have partnered with Indiegogo in the hopes of discovering and developing the next big idea in healthy aging--and raising more awareness about the importance of living healthy at every age,” Sally Susman, Pfizer’s executive vice president of corporate affairs, told FiercePharmaMarketing in an email interview.


Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

Although there will be just one winner, Pfizer anticipates that the publicity and exposure could potentially drive separate crowdfunding for some of the other projects.

The Get Old initiative began in 2014 as a Pfizer campaign to challenge misperceptions and stereotypes about aging and promote new ideas, content and perceptions around healthy aging.

- here's the press release
- see the campaign submission page

Related Articles:
Afraid of aging? Pfizer's revamped 'Get old' campaign wants you
Pfizer amps up its 'Get old' campaign with more content, more social media
Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign
Up up and away: 2015 pharma ad spending ties decade-old record


Suggested Articles

Acadia's knew it had a winner in psychosis when it called off a trial for its Nuplazid. Now analysts are seeing a blockbuster in the making.

Sandoz would still consider acquisitions, as long as they fit the Novartis unit's focus on generics and biosimilars, CEO Richard Saynor said.

Novartis is planning 80 major drug submissions in key markets over the next three years, and 25 of those could be blockbuster opportunities.